| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 38.4 | 34.6 |
| Profit before tax | 7.4 | 6.3 |
| Net income | 4.7 | 4.1 |
| EPS (diluted, $ a share) | $0.21 | $0.18 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +14.1% |
|---|---|
| Revenue, year on year | +11.0% |
| Operating margin | 23.2% |
10-Q filed with the SEC, NASDAQ: NRC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Nrc Health: key numbers
- Share price
- $25.89Close, Nov 17
- Market cap
- $549M
- Shares outstanding
- 21.22MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Commercial Physical & Biological ResearchSIC 8731
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Nrc Health
All →NRC Health Earnings Call: Key Takeaways
NRC Health returned to double-digit growth in Q3 2026, driven by a major customer implementation and strong performance in Market Insights and Governance Institute segments.
- Call
- Oct 27, 2026, 4:30 PM ET
Nrc Health Financial Results
NRC Health reported third-quarter 2026 revenue of $38.4 million, an 11% increase year-over-year, driven by the successful launch of a large customer and multi-year renewals. The company also declared a quarterly cash dividend of $0.16 per share payable in January 2027.
- Term
- Q3 2026
“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion. Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base. As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time, reinforcing our confidence in NRC Health’s ability to create long-term shareholder value.”
Trent Green, CEO of NRC Health
Nrc Health Leadership Change
NRC Health has appointed its current CEO, Trent Green, to the additional role of interim principal financial officer effective October 14, 2026. No compensation changes were made in connection with this appointment, and Mr. Green has served as the company's CEO since June 2025.